Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?
Primary percutaneous intervention (PCI) is a preferable reperfusion method in patients with STEMI. If on-time PCI is not possible, pharmacoinvasive approach is recommended that includes urgent systemic thrombolysis. Regardless the broad usage of ticagrelor in MI patients, its safety in combination w...
Main Authors: | O. V. Averkov, V. I. Vechorko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2018-09-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2949 |
Similar Items
-
Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients
by: O. V. Averkov, et al.
Published: (2019-09-01) -
THE PLACE FOR SYSTEMIC THROMBOLYSIS IN MODERN REPERFUSION METHODS FOR MYOCARDIAL INFARCTION
by: O. V. Averkov, et al.
Published: (2014-09-01) -
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Anastasiou, I., et al.
Published: (2022) -
Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
by: Matteo Vercellino, et al.
Published: (2017-04-01) -
High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis
by: K. Priti, et al.
Published: (2017-07-01)